Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
The closing price of BriaCell Therapeutics Corp (NASDAQ: BCTX) was $0.74 for the day, down -0.21% from the previous closing price of $0.75. In other words, the price has decreased by -$0.21 from its previous closing price. On the day, 0.63 million shares were traded. BCTX stock price reached its highest trading level at $0.7566 during the session, while it also had its lowest trading level at $0.71.
Ratios:
Our analysis of BCTX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.41 and its Current Ratio is at 3.41. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on February 14, 2022, initiated with a Buy rating and assigned the stock a target price of $25.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCTX now has a Market Capitalization of 13222145 and an Enterprise Value of -7892898.
Stock Price History:
The Beta on a monthly basis for BCTX is 1.06, which has changed by 0.17460322 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, BCTX has reached a high of $29.40, while it has fallen to a 52-week low of $0.69. The 50-Day Moving Average of the stock is -69.31%, while the 200-Day Moving Average is calculated to be -87.40%.
Shares Statistics:
BCTX traded an average of 1.18M shares per day over the past three months and 721970 shares per day over the past ten days. A total of 17.55M shares are outstanding, with a floating share count of 17.07M. Insiders hold about 2.74% of the company’s shares, while institutions hold 16.04% stake in the company. Shares short for BCTX as of 1752537600 were 1793918 with a Short Ratio of 1.52, compared to 1749772800 on 210323. Therefore, it implies a Short% of Shares Outstanding of 1793918 and a Short% of Float of 27.040002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
